Comparison of ciprofioxacin - Doxycycline and rifampin – Doxycycline regimens in preventing brucellosis relapse
Phase 3
- Conditions
- Brucellosis.BrucellosisA23.0, A23
- Registration Number
- IRCT2012080310482N1
- Lead Sponsor
- Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Inclusion criteria : patients with brucellosis in basis of clinical, epidemiological and serologic criteria, attended in the clinics of infectious disease in Arak university of medical sciences and age more than 17 years old.
Excusion criteria : pregnancy; age less than 17 years; endocarditis - meningitis ; spondy lities, esophagitis ; consumption of oral contraceptives or phenytion; history of brucellosis (relapse), antimicrobial therapy for more than 7 days befor attending; intolerance for oral medication and no desire for patipicating.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Relapse. Timepoint: 6 , 9 , 12 months from the begining of the study. Method of measurement: physical exam.
- Secondary Outcome Measures
Name Time Method Drug side effects. Timepoint: During the treatment. Method of measurement: physical exam.